Celgene Offers Beat-And-Raise As Bristol Merger Looms Closer

Celgene (CELG) on Tuesday reported adjusted earnings of $2.86 per share on $4.4 billion in sales for its second quarter ended June 30. In the year-earlier period, Celgene earnings were $2.16 per share on $3.81 billion in sales.